|
Thomas, A B; Hashimoto, H; Baylink, D J et al. (1996) Fluoride at mitogenic concentrations increases the steady state phosphotyrosyl phosphorylation level of cellular proteins in human bone cells. J Clin Endocrinol Metab 81:2570-8
|
|
Ohta, T; Wergedal, J E; Matsuyama, T et al. (1995) Phenytoin and fluoride act in concert to stimulate bone formation and to increase bone volume in adult male rats. Calcif Tissue Int 56:390-7
|
|
Lau, K H; Nakade, O; Barr, B et al. (1995) Phenytoin increases markers of osteogenesis for the human species in vitro and in vivo. J Clin Endocrinol Metab 80:2347-53
|
|
Ohta, T; Wergedal, J E; Gruber, H E et al. (1995) Low dose phenytoin is an osteogenic agent in the rat. Calcif Tissue Int 56:42-8
|
|
Resch, H; Libanati, C; Talbot, J et al. (1994) Pharmacokinetic profile of a new fluoride preparation: sustained-release monofluorophosphate. Calcif Tissue Int 54:7-11
|
|
Lau, K H; Wang, S P; Linkhart, T A et al. (1994) Picomolar norethindrone in vitro stimulates the cell proliferation and activity of a human osteosarcoma cell line and increases bone collagen synthesis without an effect on bone resorption. J Bone Miner Res 9:695-703
|
|
Wang, S P; Demarest, K T; Gunnet, J W et al. (1994) Development of a heterologous radioimmunoassay for canine osteocalcin. Calcif Tissue Int 55:134-40
|
|
Lau, K H; Baylink, D J (1993) Phosphotyrosyl protein phosphatases: potential regulators of cell proliferation and differentiation. Crit Rev Oncog 4:451-71
|
|
Lau, K H; Utrapiromsuk, S; Yoo, A et al. (1993) Mechanism of mitogenic action of aluminum ion on human bone cells: potential involvement of the insulin-like growth factor regulatory system. Arch Biochem Biophys 303:267-73
|
|
Libanati, C R; Baylink, D J (1992) Prevention and treatment of glucocorticoid-induced osteoporosis. A pathogenetic perspective. Chest 102:1426-35
|
Showing the most recent 10 out of 14 publications
